Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial

Anhedonia Inflammatory response
DOI: 10.1176/appi.ajp.20240142 Publication Date: 2025-04-23T07:00:31Z
ABSTRACT
The authors sought to determine whether an inflammatory challenge with lipopolysaccharide (LPS) differentially impacts symptoms of anhedonia in participants major depressive disorder high (≥3 mg/L) and low (≤1.5 serum C-reactive protein (CRP) concentrations. Sixty-eight were randomly assigned, a 1:1 ratio, receive LPS (0.8 ng/kg body weight) or placebo (saline) parallel-group double-blind design. Participants stratified according baseline CRP concentrations, yielding four groups: high-CRP (N=13), low-CRP (N=19), (N=19). Blood was sampled at baseline, 1, 1.5, 3.5, 6, 24 hours, 1 week after saline administration, concurrent assessment psychological outcomes. primary outcome measure the Snaith-Hamilton Pleasure Scale (SHAPS), contrast interest change between 1.5 hours (peak response) versus groups receiving LPS. Secondary outcomes included Montgomery-Åsberg Depression Rating (MADRS) levels three cytokines: interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF). Data analyzed linear mixed models. Significantly greater increases self-reported (on SHAPS) IL-6 observed groups. There no significant differences for TNF IL-10. MADRS not administered hours; secondary analyses showed group-by-condition-by-time interaction driven by decrease scores group. Depressed individuals systemic inflammation appeared be biologically primed respond more strongly stimuli, psychologically, this sensitization impacted symptom anhedonia, outcome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (0)